SecBot SecBot
6-K ·Filed Apr 1, 2026

GNMSF

GENMAB A/S
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001434265-26-000054
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine disclosure with no immediate trading implications. Monitor for potential future filings that might indicate activist intentions, but this standalone event does not suggest any strategic changes.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
GNMSF ▼ -1.13% at T+60d
NEUTRAL call -1.13% · α vs SPY -14.51% · entry $265.00 → $262.00
Entry = T+0 close
Apr 1, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.08%
$265.00
settled 7mo ago
T+5d
+12.60%
call +12.60% · α +8.83%
$298.38
settled 7mo ago
T+20d
-3.68%
call -3.68% · α -13.40%
$255.25
settled 6mo ago
T+60d
-1.13%
call -1.13% · α -14.51%
$262.00
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Genmab A/S announced that Orbis Investment Management Limited has acquired a 5.01% stake in the company, making it a major shareholder. This is a routine regulatory disclosure with no material financial impact.

Key Facts

  • Orbis Investment Management Limited now holds 3,221,620 shares in Genmab AS
  • This represents 5.01% of the share capital and voting rights
  • The stake crossed the 5% threshold on March 31, 2026
  • This is a standard regulatory filing under Danish capital markets rules

Financial Impact

No financial impact - this is a passive stake disclosure

ownershipvoting_rights

Risk Factors

  • Potential for future activist involvement if Orbis increases its stake
  • Market perception of institutional interest could influence sentiment

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001434265-26-000054
Document: gmab_20260401xx6k.htm0001434265-26-000054
Document: gmab_20260401xxex99d2.htm0001434265-26-000054
Document: 0001434265-26-000054-index-headers.html0001434265-26-000054
Document: 0001434265-26-000054-index.html0001434265-26-000054
Document: 0001434265-26-000054.txt0001434265-26-000054
10 reports for GNMSF
Performance horizon
Filters
Rows
Reports for GNMSF — sortable, filterable
TypeNow
May 29, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$251.55 $262.00▲ +4.15%▲ +5.45%$439.05 (+74.54%)
May 13, 2026
23w ago
6-K
NEUTRAL ★ 2/10
$268.24 $249.00▼ −7.17%▼ −6.56%$439.05 (+63.68%)
May 12, 2026
24w ago
6-K
NEUTRAL ★ 1/10
$264.64 $249.00▼ −5.91%▼ −4.18%$439.05 (+65.90%)
May 8, 2026
24w ago
6-K
NEUTRAL ★ 2/10
$259.60 $249.00▼ −4.08%▼ −3.78%$439.05 (+69.13%)
Apr 17, 2026
27w ago
6-K
NEUTRAL ★ 3/10
$281.75 $265.27▼ −5.85%▼ −11.22%$439.05 (+55.83%)
Apr 17, 2026
27w ago
6-K
NEUTRAL ★ 2/10
$281.75 $265.27▼ −5.85%▼ −11.22%$439.05 (+55.83%)
Apr 14, 2026
28w ago
6-K
NEUTRAL ★ 4/10
$273.25 $259.60▼ −5.00%▼ −11.29%$439.05 (+60.68%)
Apr 1, 2026
29w ago
6-K
NEUTRAL ★ 2/10
$265.00 $255.25▼ −3.68%▼ −13.40%$439.05 (+65.68%)
Apr 1, 2026
29w ago
6-K
NEUTRAL ★ 2/10
$265.00 $255.25▼ −3.68%▼ −13.40%$439.05 (+65.68%)
Mar 30, 2026
30w ago
6-K
NEUTRAL ★ 2/10
$265.00 $255.25▼ −3.68%▼ −13.10%$439.05 (+65.68%)
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (9h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026